The ability of IgA to inhibit the complement-mediated lysis of target red blood cells sensitized with IgG antibody.
D000818:Animals; D000918:Antibody Specificity; D001667:Binding, Competitive; D001704:Biopolymers; D003169:Complement Inactivator Proteins; D004136:Dinitrobenzenes / Q000276:immunology; D006461:Hemolysis; D007070:Immunoglobulin A / Q000276:immunology*; D007074:Immunoglobulin G / Q000276:immunology; D051379:Mice; D009194:Myeloma Proteins / Q000276:immunology; D014301:Trinitrobenzenes / Q000276:immunology
D001704:Biopolymers; D003169:Complement Inactivator Proteins; D004136:Dinitrobenzenes; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D009194:Myeloma Proteins; D014301:Trinitrobenzenes